Billionaires spend big to boost Cuomo

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Super PACs supporting Andrew Cuomo and opposing Zohran Mamdani in the New York City mayoral race have raised over $40 million, with millions…

Read More

Amazon (AMZN) Q3 earnings report 2025

Andy Jassy, CEO of Amazon, speaks during an unveiling event in New York on Feb. 26, 2025. Michael Nagle | Bloomberg | Getty Images Amazon is slated to post results for the third quarter after the closing bell Thursday. Here’s what analysts polled by LSEG are looking for: Earnings per share: $1.57 Revenue: $177.8 billion…

Read More

How Ravens look to defy 1% odds for a historic comeback

Jamison HensleyOct 30, 2025, 06:00 AM ET Close Jamison Hensley is a reporter covering the Baltimore Ravens for ESPN. Jamison joined ESPN in 2011, covering the AFC North before focusing exclusively on the Ravens beginning in 2013. Jamison won the National Sports Media Association Maryland Sportswriter of the Year award in 2018, and he authored…

Read More

Trump administration nixes public service student loan relief for those involved in 'unlawful activities'

The Trump administration announced a final rule Thursday to change the Public Service Loan Forgiveness (PSLF) program so that employees at organizations involved in “unlawful activities” will not be eligible for student loan relief. While the administration says the move is to protect taxpayers, opponents worry the government will go after certain groups for political…

Read More

Eli Lilly (LLY) earnings Q3 2025

Eli Lilly on Thursday reported third-quarter earnings and revenue that topped estimates and hiked its full-year outlook, as the company continued to see strong demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro. Shares of the company rose more than 2% in morning trading on Thursday. The pharmaceutical giant now expects its…

Read More